Source link : https://www.newshealth.biz/health-news/thyroid-drug-glp-1s-renal-benefit-menopause-musculoskeletal-syndrome/
The thyroid medication levothyroxine may be associated with bone loss, according to a study that will be presented at the Radiological Society of North America’s annual meeting. In a phase II study, investigational maridebart cafraglutide (MariTide) yielded around 20% weight loss at 52 weeks, Amgen announced. A meta-analysis of 11 randomized trials in type 2 […]
Author : News Health
Publish date : 2024-11-26 19:14:05
Copyright for syndicated content belongs to the linked Source.